Concepedia

Kyla Collins

KC

Statistics

Publications

8

Citations

786

H-Index

8

Active since

2015

Affiliations

Eli Lilly (United States)(Current)

The University of Texas Southwestern Medical Center

University of North Carolina at Chapel Hill

Kyla Collins is an author at Eli Lilly (United States) specializing in signal transduction, cell signaling, and diabetes mellitus.

Publications per year

2015–2024

8

Publications

8

Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains

Timothy J. Stuhlmiller, Samantha M. Miller, Jon S. Zawistowski et al. · Cell Reports · 2015 · 281 citations · Full text

, , +17

GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice

Ricardo J. Samms, Michael E. Christe, Kyla Collins et al. · Journal of Clinical Investigation · 2021 · 227 citations · Full text

, , +17

The role of physical activity in improving physical fitness in children with intellectual and developmental disabilities

Kyla Collins, Kerri L. Staples · Research in Developmental Disabilities · 2017 · 89 citations

, , +16

Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue

Ricardo J. Samms, Guofang Zhang, Wentao He et al. · Molecular Metabolism · 2022 · 82 citations · Full text

, , +17

The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice

Xinxin Yu, Shiuhwei Chen, Jan‐Bernd Funcke et al. · Cell Metabolism · 2024 · 52 citations · Full text

, , +17

1–5 of 8